Global Animal Model
Global Animal Model

Animal Model Comprehensive Study by Type (Rats, Mice, Rabbits, Dogs, Pigs, Cats, Others), Application (Physiology, Toxicology, Cancer Research, Neurological Research, Biomedical Research, Genetic Research, Xenotransplantation), End User (Academic & Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Others) Players and Region - Global Market Outlook to 2024

Animal Model Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 7.38%  

May 2019 Edition 250 Pages 220 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Due to upsurging research and developments in developing a number of novel therapies, an animal model market will show significant growth over the forecasted period. In addition to this, growing need to innovate and develop new types of novel drugs in order to cope up with the upsurging demand will further improve demand for animal species as a sample. Moreover, over the last few decades, a variety of genetic disorders have been raised across the globe, thus the need to carry out research studies of those diseases and human pathology will further escalate the demand for Aminal Model. Any animal species are performed and tested and chosen for pathological and biological studies are known as animal models. These models are utilized on the back of their functional resemblance to human bodies. However, various guidelines and stringent government regulations have restricted the applications of animal models.

The market study is being classified by Type (Rats, Mice, Rabbits, Dogs, Pigs, Cats and Others), by Application (Physiology, Toxicology, Cancer Research, Neurological Research, Biomedical Research, Genetic Research and Xenotransplantation) and major geographies with country level break-up. According to AMA, the Global Animal Model market is expected to see growth rate of 7.38% and may see market size of USD2618.8 Million by 2024.

Charles River Laboratories International, Inc. (United States), Horizon Discovery Group plc (United Kingdom), Advinus Therapeutics Limited (India), Jackson Laboratory (United States), Trans Genic Inc. (Japan), Taconic Biosciences, Inc. (United States), Genoway SA (France), Eurofins Scientific SE (Luxembourg), Crown Bioscience, Inc. (United States) and Envigo CRS SA (Spain) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Beijing Vital Star Biotechnology (China), Pharmalegacy Biotechnology (China) and Pharmaron, Inc. (United States).

The Players having a strong hold in the market are Charles River, Horizon Discovery, Advinus Therapeutics, Jackson Laboratory, and Trans Genic. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Animal Model market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Animal Model market by Type, Application and Region.

On the basis of geography, the market of Animal Model has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Academic & Research Institutions will boost the Animal Model market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Upsurging Research and Developments in Developing a Number of Novel Therapies
  • Growing Need to Innovate and Develop New Types of Novel Drugs

Market Trend
  • Increasing Adoption of Mouse Models in the Field of Cancer Research
  • Development of Animal Models to Understand the Bases of Memory and Decision Making

Restraints
  • Comparatively Higher Costs Associated with Animal Model-Based Research
  • Stringent Government Regulations on the Use of Animal Species for Reseach and Developments

Opportunities
  • Rising Need for Animal Models for the Treatment of Alzheimer’s Disease
  • Avails a Better Understanding of the Disease

Challenges
  • Lack of R&D Activities in Underdeveloped Economies
  • Hard to Cope up with the Volatile Demand for Animal Model


Market Leaders and their expansionary development strategies
In July 2017, Pharmatest Services had partnered with Taconic Biosciences in a bid to manufacture a new tentative mouse model with a human immune system, precisely made to research bone metastasis. Scientists of the Center for Infectious Disease Research (CIDR) have also discovered an antibody preventing malaria using a unique humanized mouse liver model.
According to the World Health Organization (WHO), currently, dementia affects nearly 10 million people in Europe and is likely to double by 2030. Growing instances of neurological disorders in the European region is assisting the research and development activities using various biotechnological solutions such as highering Animal Model. In addition to this, the European Research Council has also established an advanced project named ‘CONCEPT’ in order to understand bases of memory, decision making, and perception using rodents and other technically advanced instruments.


Key Target Audience
Animal Model Providers, Animal Model Distributors and Traders, Biotechnology Industry Associations, Pharmaceutical Organizations, Academic and Research Institutions, Government Agencies, Animal Husbandries and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Rats
  • Mice
  • Rabbits
  • Dogs
  • Pigs
  • Cats
  • Others
By Application
  • Physiology
  • Toxicology
  • Cancer Research
  • Neurological Research
  • Biomedical Research
  • Genetic Research
  • Xenotransplantation
By End User
  • Academic & Research Institutions
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Upsurging Research and Developments in Developing a Number of Novel Therapies
      • 3.2.2. Growing Need to Innovate and Develop New Types of Novel Drugs
    • 3.3. Market Challenges
      • 3.3.1. Lack of R&D Activities in Underdeveloped Economies
      • 3.3.2. Hard to Cope up with the Volatile Demand for Animal Model
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption of Mouse Models in the Field of Cancer Research
      • 3.4.2. Development of Animal Models to Understand the Bases of Memory and Decision Making
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Model, by Type, Application, End User and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Animal Model (Value)
      • 5.2.1. Global Animal Model by: Type (Value)
        • 5.2.1.1. Rats
        • 5.2.1.2. Mice
        • 5.2.1.3. Rabbits
        • 5.2.1.4. Dogs
        • 5.2.1.5. Pigs
        • 5.2.1.6. Cats
        • 5.2.1.7. Others
      • 5.2.2. Global Animal Model by: Application (Value)
        • 5.2.2.1. Physiology
        • 5.2.2.2. Toxicology
        • 5.2.2.3. Cancer Research
        • 5.2.2.4. Neurological Research
        • 5.2.2.5. Biomedical Research
        • 5.2.2.6. Genetic Research
        • 5.2.2.7. Xenotransplantation
      • 5.2.3. Global Animal Model by: End User (Value)
        • 5.2.3.1. Academic & Research Institutions
        • 5.2.3.2. Pharmaceutical Companies
        • 5.2.3.3. Biotechnology Companies
        • 5.2.3.4. Contract Research Organizations (CROs)
        • 5.2.3.5. Others
      • 5.2.4. Global Animal Model Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Animal Model (Volume)
      • 5.3.1. Global Animal Model by: Type (Volume)
        • 5.3.1.1. Rats
        • 5.3.1.2. Mice
        • 5.3.1.3. Rabbits
        • 5.3.1.4. Dogs
        • 5.3.1.5. Pigs
        • 5.3.1.6. Cats
        • 5.3.1.7. Others
      • 5.3.2. Global Animal Model by: Application (Volume)
        • 5.3.2.1. Physiology
        • 5.3.2.2. Toxicology
        • 5.3.2.3. Cancer Research
        • 5.3.2.4. Neurological Research
        • 5.3.2.5. Biomedical Research
        • 5.3.2.6. Genetic Research
        • 5.3.2.7. Xenotransplantation
      • 5.3.3. Global Animal Model by: End User (Volume)
        • 5.3.3.1. Academic & Research Institutions
        • 5.3.3.2. Pharmaceutical Companies
        • 5.3.3.3. Biotechnology Companies
        • 5.3.3.4. Contract Research Organizations (CROs)
        • 5.3.3.5. Others
      • 5.3.4. Global Animal Model Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Animal Model (Price)
      • 5.4.1. Global Animal Model by: Type (Price)
  • 6. Animal Model: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Charles River Laboratories International, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Horizon Discovery Group plc (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Advinus Therapeutics Limited (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Jackson Laboratory (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Trans Genic Inc. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Taconic Biosciences, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Genoway SA (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eurofins Scientific SE (Luxembourg)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Crown Bioscience, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Envigo CRS SA (Spain)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Animal Model Sale, by Type, Application, End User and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Animal Model (Value)
      • 7.2.1. Global Animal Model by: Type (Value)
        • 7.2.1.1. Rats
        • 7.2.1.2. Mice
        • 7.2.1.3. Rabbits
        • 7.2.1.4. Dogs
        • 7.2.1.5. Pigs
        • 7.2.1.6. Cats
        • 7.2.1.7. Others
      • 7.2.2. Global Animal Model by: Application (Value)
        • 7.2.2.1. Physiology
        • 7.2.2.2. Toxicology
        • 7.2.2.3. Cancer Research
        • 7.2.2.4. Neurological Research
        • 7.2.2.5. Biomedical Research
        • 7.2.2.6. Genetic Research
        • 7.2.2.7. Xenotransplantation
      • 7.2.3. Global Animal Model by: End User (Value)
        • 7.2.3.1. Academic & Research Institutions
        • 7.2.3.2. Pharmaceutical Companies
        • 7.2.3.3. Biotechnology Companies
        • 7.2.3.4. Contract Research Organizations (CROs)
        • 7.2.3.5. Others
      • 7.2.4. Global Animal Model Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Animal Model (Volume)
      • 7.3.1. Global Animal Model by: Type (Volume)
        • 7.3.1.1. Rats
        • 7.3.1.2. Mice
        • 7.3.1.3. Rabbits
        • 7.3.1.4. Dogs
        • 7.3.1.5. Pigs
        • 7.3.1.6. Cats
        • 7.3.1.7. Others
      • 7.3.2. Global Animal Model by: Application (Volume)
        • 7.3.2.1. Physiology
        • 7.3.2.2. Toxicology
        • 7.3.2.3. Cancer Research
        • 7.3.2.4. Neurological Research
        • 7.3.2.5. Biomedical Research
        • 7.3.2.6. Genetic Research
        • 7.3.2.7. Xenotransplantation
      • 7.3.3. Global Animal Model by: End User (Volume)
        • 7.3.3.1. Academic & Research Institutions
        • 7.3.3.2. Pharmaceutical Companies
        • 7.3.3.3. Biotechnology Companies
        • 7.3.3.4. Contract Research Organizations (CROs)
        • 7.3.3.5. Others
      • 7.3.4. Global Animal Model Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Animal Model (Price)
      • 7.4.1. Global Animal Model by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Model: by Type(USD Million)
  • Table 2. Animal Model Rats , by Region USD Million (2013-2018)
  • Table 3. Animal Model Mice , by Region USD Million (2013-2018)
  • Table 4. Animal Model Rabbits , by Region USD Million (2013-2018)
  • Table 5. Animal Model Dogs , by Region USD Million (2013-2018)
  • Table 6. Animal Model Pigs , by Region USD Million (2013-2018)
  • Table 7. Animal Model Cats , by Region USD Million (2013-2018)
  • Table 8. Animal Model Others , by Region USD Million (2013-2018)
  • Table 9. Animal Model: by Application(USD Million)
  • Table 10. Animal Model Physiology , by Region USD Million (2013-2018)
  • Table 11. Animal Model Toxicology , by Region USD Million (2013-2018)
  • Table 12. Animal Model Cancer Research , by Region USD Million (2013-2018)
  • Table 13. Animal Model Neurological Research , by Region USD Million (2013-2018)
  • Table 14. Animal Model Biomedical Research , by Region USD Million (2013-2018)
  • Table 15. Animal Model Genetic Research , by Region USD Million (2013-2018)
  • Table 16. Animal Model Xenotransplantation , by Region USD Million (2013-2018)
  • Table 17. Animal Model: by End User(USD Million)
  • Table 18. Animal Model Academic & Research Institutions , by Region USD Million (2013-2018)
  • Table 19. Animal Model Pharmaceutical Companies , by Region USD Million (2013-2018)
  • Table 20. Animal Model Biotechnology Companies , by Region USD Million (2013-2018)
  • Table 21. Animal Model Contract Research Organizations (CROs) , by Region USD Million (2013-2018)
  • Table 22. Animal Model Others , by Region USD Million (2013-2018)
  • Table 23. South America Animal Model, by Country USD Million (2013-2018)
  • Table 24. South America Animal Model, by Type USD Million (2013-2018)
  • Table 25. South America Animal Model, by Application USD Million (2013-2018)
  • Table 26. South America Animal Model, by End User USD Million (2013-2018)
  • Table 27. Brazil Animal Model, by Type USD Million (2013-2018)
  • Table 28. Brazil Animal Model, by Application USD Million (2013-2018)
  • Table 29. Brazil Animal Model, by End User USD Million (2013-2018)
  • Table 30. Argentina Animal Model, by Type USD Million (2013-2018)
  • Table 31. Argentina Animal Model, by Application USD Million (2013-2018)
  • Table 32. Argentina Animal Model, by End User USD Million (2013-2018)
  • Table 33. Rest of South America Animal Model, by Type USD Million (2013-2018)
  • Table 34. Rest of South America Animal Model, by Application USD Million (2013-2018)
  • Table 35. Rest of South America Animal Model, by End User USD Million (2013-2018)
  • Table 36. Asia Pacific Animal Model, by Country USD Million (2013-2018)
  • Table 37. Asia Pacific Animal Model, by Type USD Million (2013-2018)
  • Table 38. Asia Pacific Animal Model, by Application USD Million (2013-2018)
  • Table 39. Asia Pacific Animal Model, by End User USD Million (2013-2018)
  • Table 40. China Animal Model, by Type USD Million (2013-2018)
  • Table 41. China Animal Model, by Application USD Million (2013-2018)
  • Table 42. China Animal Model, by End User USD Million (2013-2018)
  • Table 43. Japan Animal Model, by Type USD Million (2013-2018)
  • Table 44. Japan Animal Model, by Application USD Million (2013-2018)
  • Table 45. Japan Animal Model, by End User USD Million (2013-2018)
  • Table 46. India Animal Model, by Type USD Million (2013-2018)
  • Table 47. India Animal Model, by Application USD Million (2013-2018)
  • Table 48. India Animal Model, by End User USD Million (2013-2018)
  • Table 49. South Korea Animal Model, by Type USD Million (2013-2018)
  • Table 50. South Korea Animal Model, by Application USD Million (2013-2018)
  • Table 51. South Korea Animal Model, by End User USD Million (2013-2018)
  • Table 52. Taiwan Animal Model, by Type USD Million (2013-2018)
  • Table 53. Taiwan Animal Model, by Application USD Million (2013-2018)
  • Table 54. Taiwan Animal Model, by End User USD Million (2013-2018)
  • Table 55. Australia Animal Model, by Type USD Million (2013-2018)
  • Table 56. Australia Animal Model, by Application USD Million (2013-2018)
  • Table 57. Australia Animal Model, by End User USD Million (2013-2018)
  • Table 58. Rest of Asia-Pacific Animal Model, by Type USD Million (2013-2018)
  • Table 59. Rest of Asia-Pacific Animal Model, by Application USD Million (2013-2018)
  • Table 60. Rest of Asia-Pacific Animal Model, by End User USD Million (2013-2018)
  • Table 61. Europe Animal Model, by Country USD Million (2013-2018)
  • Table 62. Europe Animal Model, by Type USD Million (2013-2018)
  • Table 63. Europe Animal Model, by Application USD Million (2013-2018)
  • Table 64. Europe Animal Model, by End User USD Million (2013-2018)
  • Table 65. Germany Animal Model, by Type USD Million (2013-2018)
  • Table 66. Germany Animal Model, by Application USD Million (2013-2018)
  • Table 67. Germany Animal Model, by End User USD Million (2013-2018)
  • Table 68. France Animal Model, by Type USD Million (2013-2018)
  • Table 69. France Animal Model, by Application USD Million (2013-2018)
  • Table 70. France Animal Model, by End User USD Million (2013-2018)
  • Table 71. Italy Animal Model, by Type USD Million (2013-2018)
  • Table 72. Italy Animal Model, by Application USD Million (2013-2018)
  • Table 73. Italy Animal Model, by End User USD Million (2013-2018)
  • Table 74. United Kingdom Animal Model, by Type USD Million (2013-2018)
  • Table 75. United Kingdom Animal Model, by Application USD Million (2013-2018)
  • Table 76. United Kingdom Animal Model, by End User USD Million (2013-2018)
  • Table 77. Netherlands Animal Model, by Type USD Million (2013-2018)
  • Table 78. Netherlands Animal Model, by Application USD Million (2013-2018)
  • Table 79. Netherlands Animal Model, by End User USD Million (2013-2018)
  • Table 80. Rest of Europe Animal Model, by Type USD Million (2013-2018)
  • Table 81. Rest of Europe Animal Model, by Application USD Million (2013-2018)
  • Table 82. Rest of Europe Animal Model, by End User USD Million (2013-2018)
  • Table 83. MEA Animal Model, by Country USD Million (2013-2018)
  • Table 84. MEA Animal Model, by Type USD Million (2013-2018)
  • Table 85. MEA Animal Model, by Application USD Million (2013-2018)
  • Table 86. MEA Animal Model, by End User USD Million (2013-2018)
  • Table 87. Middle East Animal Model, by Type USD Million (2013-2018)
  • Table 88. Middle East Animal Model, by Application USD Million (2013-2018)
  • Table 89. Middle East Animal Model, by End User USD Million (2013-2018)
  • Table 90. Africa Animal Model, by Type USD Million (2013-2018)
  • Table 91. Africa Animal Model, by Application USD Million (2013-2018)
  • Table 92. Africa Animal Model, by End User USD Million (2013-2018)
  • Table 93. North America Animal Model, by Country USD Million (2013-2018)
  • Table 94. North America Animal Model, by Type USD Million (2013-2018)
  • Table 95. North America Animal Model, by Application USD Million (2013-2018)
  • Table 96. North America Animal Model, by End User USD Million (2013-2018)
  • Table 97. United States Animal Model, by Type USD Million (2013-2018)
  • Table 98. United States Animal Model, by Application USD Million (2013-2018)
  • Table 99. United States Animal Model, by End User USD Million (2013-2018)
  • Table 100. Canada Animal Model, by Type USD Million (2013-2018)
  • Table 101. Canada Animal Model, by Application USD Million (2013-2018)
  • Table 102. Canada Animal Model, by End User USD Million (2013-2018)
  • Table 103. Mexico Animal Model, by Type USD Million (2013-2018)
  • Table 104. Mexico Animal Model, by Application USD Million (2013-2018)
  • Table 105. Mexico Animal Model, by End User USD Million (2013-2018)
  • Table 106. Animal Model Sales: by Type(K Units)
  • Table 107. Animal Model Sales Rats , by Region K Units (2013-2018)
  • Table 108. Animal Model Sales Mice , by Region K Units (2013-2018)
  • Table 109. Animal Model Sales Rabbits , by Region K Units (2013-2018)
  • Table 110. Animal Model Sales Dogs , by Region K Units (2013-2018)
  • Table 111. Animal Model Sales Pigs , by Region K Units (2013-2018)
  • Table 112. Animal Model Sales Cats , by Region K Units (2013-2018)
  • Table 113. Animal Model Sales Others , by Region K Units (2013-2018)
  • Table 114. Animal Model Sales: by Application(K Units)
  • Table 115. Animal Model Sales Physiology , by Region K Units (2013-2018)
  • Table 116. Animal Model Sales Toxicology , by Region K Units (2013-2018)
  • Table 117. Animal Model Sales Cancer Research , by Region K Units (2013-2018)
  • Table 118. Animal Model Sales Neurological Research , by Region K Units (2013-2018)
  • Table 119. Animal Model Sales Biomedical Research , by Region K Units (2013-2018)
  • Table 120. Animal Model Sales Genetic Research , by Region K Units (2013-2018)
  • Table 121. Animal Model Sales Xenotransplantation , by Region K Units (2013-2018)
  • Table 122. Animal Model Sales: by End User(K Units)
  • Table 123. Animal Model Sales Academic & Research Institutions , by Region K Units (2013-2018)
  • Table 124. Animal Model Sales Pharmaceutical Companies , by Region K Units (2013-2018)
  • Table 125. Animal Model Sales Biotechnology Companies , by Region K Units (2013-2018)
  • Table 126. Animal Model Sales Contract Research Organizations (CROs) , by Region K Units (2013-2018)
  • Table 127. Animal Model Sales Others , by Region K Units (2013-2018)
  • Table 128. South America Animal Model Sales, by Country K Units (2013-2018)
  • Table 129. South America Animal Model Sales, by Type K Units (2013-2018)
  • Table 130. South America Animal Model Sales, by Application K Units (2013-2018)
  • Table 131. South America Animal Model Sales, by End User K Units (2013-2018)
  • Table 132. Brazil Animal Model Sales, by Type K Units (2013-2018)
  • Table 133. Brazil Animal Model Sales, by Application K Units (2013-2018)
  • Table 134. Brazil Animal Model Sales, by End User K Units (2013-2018)
  • Table 135. Argentina Animal Model Sales, by Type K Units (2013-2018)
  • Table 136. Argentina Animal Model Sales, by Application K Units (2013-2018)
  • Table 137. Argentina Animal Model Sales, by End User K Units (2013-2018)
  • Table 138. Rest of South America Animal Model Sales, by Type K Units (2013-2018)
  • Table 139. Rest of South America Animal Model Sales, by Application K Units (2013-2018)
  • Table 140. Rest of South America Animal Model Sales, by End User K Units (2013-2018)
  • Table 141. Asia Pacific Animal Model Sales, by Country K Units (2013-2018)
  • Table 142. Asia Pacific Animal Model Sales, by Type K Units (2013-2018)
  • Table 143. Asia Pacific Animal Model Sales, by Application K Units (2013-2018)
  • Table 144. Asia Pacific Animal Model Sales, by End User K Units (2013-2018)
  • Table 145. China Animal Model Sales, by Type K Units (2013-2018)
  • Table 146. China Animal Model Sales, by Application K Units (2013-2018)
  • Table 147. China Animal Model Sales, by End User K Units (2013-2018)
  • Table 148. Japan Animal Model Sales, by Type K Units (2013-2018)
  • Table 149. Japan Animal Model Sales, by Application K Units (2013-2018)
  • Table 150. Japan Animal Model Sales, by End User K Units (2013-2018)
  • Table 151. India Animal Model Sales, by Type K Units (2013-2018)
  • Table 152. India Animal Model Sales, by Application K Units (2013-2018)
  • Table 153. India Animal Model Sales, by End User K Units (2013-2018)
  • Table 154. South Korea Animal Model Sales, by Type K Units (2013-2018)
  • Table 155. South Korea Animal Model Sales, by Application K Units (2013-2018)
  • Table 156. South Korea Animal Model Sales, by End User K Units (2013-2018)
  • Table 157. Taiwan Animal Model Sales, by Type K Units (2013-2018)
  • Table 158. Taiwan Animal Model Sales, by Application K Units (2013-2018)
  • Table 159. Taiwan Animal Model Sales, by End User K Units (2013-2018)
  • Table 160. Australia Animal Model Sales, by Type K Units (2013-2018)
  • Table 161. Australia Animal Model Sales, by Application K Units (2013-2018)
  • Table 162. Australia Animal Model Sales, by End User K Units (2013-2018)
  • Table 163. Rest of Asia-Pacific Animal Model Sales, by Type K Units (2013-2018)
  • Table 164. Rest of Asia-Pacific Animal Model Sales, by Application K Units (2013-2018)
  • Table 165. Rest of Asia-Pacific Animal Model Sales, by End User K Units (2013-2018)
  • Table 166. Europe Animal Model Sales, by Country K Units (2013-2018)
  • Table 167. Europe Animal Model Sales, by Type K Units (2013-2018)
  • Table 168. Europe Animal Model Sales, by Application K Units (2013-2018)
  • Table 169. Europe Animal Model Sales, by End User K Units (2013-2018)
  • Table 170. Germany Animal Model Sales, by Type K Units (2013-2018)
  • Table 171. Germany Animal Model Sales, by Application K Units (2013-2018)
  • Table 172. Germany Animal Model Sales, by End User K Units (2013-2018)
  • Table 173. France Animal Model Sales, by Type K Units (2013-2018)
  • Table 174. France Animal Model Sales, by Application K Units (2013-2018)
  • Table 175. France Animal Model Sales, by End User K Units (2013-2018)
  • Table 176. Italy Animal Model Sales, by Type K Units (2013-2018)
  • Table 177. Italy Animal Model Sales, by Application K Units (2013-2018)
  • Table 178. Italy Animal Model Sales, by End User K Units (2013-2018)
  • Table 179. United Kingdom Animal Model Sales, by Type K Units (2013-2018)
  • Table 180. United Kingdom Animal Model Sales, by Application K Units (2013-2018)
  • Table 181. United Kingdom Animal Model Sales, by End User K Units (2013-2018)
  • Table 182. Netherlands Animal Model Sales, by Type K Units (2013-2018)
  • Table 183. Netherlands Animal Model Sales, by Application K Units (2013-2018)
  • Table 184. Netherlands Animal Model Sales, by End User K Units (2013-2018)
  • Table 185. Rest of Europe Animal Model Sales, by Type K Units (2013-2018)
  • Table 186. Rest of Europe Animal Model Sales, by Application K Units (2013-2018)
  • Table 187. Rest of Europe Animal Model Sales, by End User K Units (2013-2018)
  • Table 188. MEA Animal Model Sales, by Country K Units (2013-2018)
  • Table 189. MEA Animal Model Sales, by Type K Units (2013-2018)
  • Table 190. MEA Animal Model Sales, by Application K Units (2013-2018)
  • Table 191. MEA Animal Model Sales, by End User K Units (2013-2018)
  • Table 192. Middle East Animal Model Sales, by Type K Units (2013-2018)
  • Table 193. Middle East Animal Model Sales, by Application K Units (2013-2018)
  • Table 194. Middle East Animal Model Sales, by End User K Units (2013-2018)
  • Table 195. Africa Animal Model Sales, by Type K Units (2013-2018)
  • Table 196. Africa Animal Model Sales, by Application K Units (2013-2018)
  • Table 197. Africa Animal Model Sales, by End User K Units (2013-2018)
  • Table 198. North America Animal Model Sales, by Country K Units (2013-2018)
  • Table 199. North America Animal Model Sales, by Type K Units (2013-2018)
  • Table 200. North America Animal Model Sales, by Application K Units (2013-2018)
  • Table 201. North America Animal Model Sales, by End User K Units (2013-2018)
  • Table 202. United States Animal Model Sales, by Type K Units (2013-2018)
  • Table 203. United States Animal Model Sales, by Application K Units (2013-2018)
  • Table 204. United States Animal Model Sales, by End User K Units (2013-2018)
  • Table 205. Canada Animal Model Sales, by Type K Units (2013-2018)
  • Table 206. Canada Animal Model Sales, by Application K Units (2013-2018)
  • Table 207. Canada Animal Model Sales, by End User K Units (2013-2018)
  • Table 208. Mexico Animal Model Sales, by Type K Units (2013-2018)
  • Table 209. Mexico Animal Model Sales, by Application K Units (2013-2018)
  • Table 210. Mexico Animal Model Sales, by End User K Units (2013-2018)
  • Table 211. Animal Model: by Type(USD/Units)
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. Company Basic Information, Sales Area and Its Competitors
  • Table 218. Company Basic Information, Sales Area and Its Competitors
  • Table 219. Company Basic Information, Sales Area and Its Competitors
  • Table 220. Company Basic Information, Sales Area and Its Competitors
  • Table 221. Company Basic Information, Sales Area and Its Competitors
  • Table 222. Animal Model: by Type(USD Million)
  • Table 223. Animal Model Rats , by Region USD Million (2019-2024)
  • Table 224. Animal Model Mice , by Region USD Million (2019-2024)
  • Table 225. Animal Model Rabbits , by Region USD Million (2019-2024)
  • Table 226. Animal Model Dogs , by Region USD Million (2019-2024)
  • Table 227. Animal Model Pigs , by Region USD Million (2019-2024)
  • Table 228. Animal Model Cats , by Region USD Million (2019-2024)
  • Table 229. Animal Model Others , by Region USD Million (2019-2024)
  • Table 230. Animal Model: by Application(USD Million)
  • Table 231. Animal Model Physiology , by Region USD Million (2019-2024)
  • Table 232. Animal Model Toxicology , by Region USD Million (2019-2024)
  • Table 233. Animal Model Cancer Research , by Region USD Million (2019-2024)
  • Table 234. Animal Model Neurological Research , by Region USD Million (2019-2024)
  • Table 235. Animal Model Biomedical Research , by Region USD Million (2019-2024)
  • Table 236. Animal Model Genetic Research , by Region USD Million (2019-2024)
  • Table 237. Animal Model Xenotransplantation , by Region USD Million (2019-2024)
  • Table 238. Animal Model: by End User(USD Million)
  • Table 239. Animal Model Academic & Research Institutions , by Region USD Million (2019-2024)
  • Table 240. Animal Model Pharmaceutical Companies , by Region USD Million (2019-2024)
  • Table 241. Animal Model Biotechnology Companies , by Region USD Million (2019-2024)
  • Table 242. Animal Model Contract Research Organizations (CROs) , by Region USD Million (2019-2024)
  • Table 243. Animal Model Others , by Region USD Million (2019-2024)
  • Table 244. South America Animal Model, by Country USD Million (2019-2024)
  • Table 245. South America Animal Model, by Type USD Million (2019-2024)
  • Table 246. South America Animal Model, by Application USD Million (2019-2024)
  • Table 247. South America Animal Model, by End User USD Million (2019-2024)
  • Table 248. Brazil Animal Model, by Type USD Million (2019-2024)
  • Table 249. Brazil Animal Model, by Application USD Million (2019-2024)
  • Table 250. Brazil Animal Model, by End User USD Million (2019-2024)
  • Table 251. Argentina Animal Model, by Type USD Million (2019-2024)
  • Table 252. Argentina Animal Model, by Application USD Million (2019-2024)
  • Table 253. Argentina Animal Model, by End User USD Million (2019-2024)
  • Table 254. Rest of South America Animal Model, by Type USD Million (2019-2024)
  • Table 255. Rest of South America Animal Model, by Application USD Million (2019-2024)
  • Table 256. Rest of South America Animal Model, by End User USD Million (2019-2024)
  • Table 257. Asia Pacific Animal Model, by Country USD Million (2019-2024)
  • Table 258. Asia Pacific Animal Model, by Type USD Million (2019-2024)
  • Table 259. Asia Pacific Animal Model, by Application USD Million (2019-2024)
  • Table 260. Asia Pacific Animal Model, by End User USD Million (2019-2024)
  • Table 261. China Animal Model, by Type USD Million (2019-2024)
  • Table 262. China Animal Model, by Application USD Million (2019-2024)
  • Table 263. China Animal Model, by End User USD Million (2019-2024)
  • Table 264. Japan Animal Model, by Type USD Million (2019-2024)
  • Table 265. Japan Animal Model, by Application USD Million (2019-2024)
  • Table 266. Japan Animal Model, by End User USD Million (2019-2024)
  • Table 267. India Animal Model, by Type USD Million (2019-2024)
  • Table 268. India Animal Model, by Application USD Million (2019-2024)
  • Table 269. India Animal Model, by End User USD Million (2019-2024)
  • Table 270. South Korea Animal Model, by Type USD Million (2019-2024)
  • Table 271. South Korea Animal Model, by Application USD Million (2019-2024)
  • Table 272. South Korea Animal Model, by End User USD Million (2019-2024)
  • Table 273. Taiwan Animal Model, by Type USD Million (2019-2024)
  • Table 274. Taiwan Animal Model, by Application USD Million (2019-2024)
  • Table 275. Taiwan Animal Model, by End User USD Million (2019-2024)
  • Table 276. Australia Animal Model, by Type USD Million (2019-2024)
  • Table 277. Australia Animal Model, by Application USD Million (2019-2024)
  • Table 278. Australia Animal Model, by End User USD Million (2019-2024)
  • Table 279. Rest of Asia-Pacific Animal Model, by Type USD Million (2019-2024)
  • Table 280. Rest of Asia-Pacific Animal Model, by Application USD Million (2019-2024)
  • Table 281. Rest of Asia-Pacific Animal Model, by End User USD Million (2019-2024)
  • Table 282. Europe Animal Model, by Country USD Million (2019-2024)
  • Table 283. Europe Animal Model, by Type USD Million (2019-2024)
  • Table 284. Europe Animal Model, by Application USD Million (2019-2024)
  • Table 285. Europe Animal Model, by End User USD Million (2019-2024)
  • Table 286. Germany Animal Model, by Type USD Million (2019-2024)
  • Table 287. Germany Animal Model, by Application USD Million (2019-2024)
  • Table 288. Germany Animal Model, by End User USD Million (2019-2024)
  • Table 289. France Animal Model, by Type USD Million (2019-2024)
  • Table 290. France Animal Model, by Application USD Million (2019-2024)
  • Table 291. France Animal Model, by End User USD Million (2019-2024)
  • Table 292. Italy Animal Model, by Type USD Million (2019-2024)
  • Table 293. Italy Animal Model, by Application USD Million (2019-2024)
  • Table 294. Italy Animal Model, by End User USD Million (2019-2024)
  • Table 295. United Kingdom Animal Model, by Type USD Million (2019-2024)
  • Table 296. United Kingdom Animal Model, by Application USD Million (2019-2024)
  • Table 297. United Kingdom Animal Model, by End User USD Million (2019-2024)
  • Table 298. Netherlands Animal Model, by Type USD Million (2019-2024)
  • Table 299. Netherlands Animal Model, by Application USD Million (2019-2024)
  • Table 300. Netherlands Animal Model, by End User USD Million (2019-2024)
  • Table 301. Rest of Europe Animal Model, by Type USD Million (2019-2024)
  • Table 302. Rest of Europe Animal Model, by Application USD Million (2019-2024)
  • Table 303. Rest of Europe Animal Model, by End User USD Million (2019-2024)
  • Table 304. MEA Animal Model, by Country USD Million (2019-2024)
  • Table 305. MEA Animal Model, by Type USD Million (2019-2024)
  • Table 306. MEA Animal Model, by Application USD Million (2019-2024)
  • Table 307. MEA Animal Model, by End User USD Million (2019-2024)
  • Table 308. Middle East Animal Model, by Type USD Million (2019-2024)
  • Table 309. Middle East Animal Model, by Application USD Million (2019-2024)
  • Table 310. Middle East Animal Model, by End User USD Million (2019-2024)
  • Table 311. Africa Animal Model, by Type USD Million (2019-2024)
  • Table 312. Africa Animal Model, by Application USD Million (2019-2024)
  • Table 313. Africa Animal Model, by End User USD Million (2019-2024)
  • Table 314. North America Animal Model, by Country USD Million (2019-2024)
  • Table 315. North America Animal Model, by Type USD Million (2019-2024)
  • Table 316. North America Animal Model, by Application USD Million (2019-2024)
  • Table 317. North America Animal Model, by End User USD Million (2019-2024)
  • Table 318. United States Animal Model, by Type USD Million (2019-2024)
  • Table 319. United States Animal Model, by Application USD Million (2019-2024)
  • Table 320. United States Animal Model, by End User USD Million (2019-2024)
  • Table 321. Canada Animal Model, by Type USD Million (2019-2024)
  • Table 322. Canada Animal Model, by Application USD Million (2019-2024)
  • Table 323. Canada Animal Model, by End User USD Million (2019-2024)
  • Table 324. Mexico Animal Model, by Type USD Million (2019-2024)
  • Table 325. Mexico Animal Model, by Application USD Million (2019-2024)
  • Table 326. Mexico Animal Model, by End User USD Million (2019-2024)
  • Table 327. Animal Model Sales: by Type(K Units)
  • Table 328. Animal Model Sales Rats , by Region K Units (2019-2024)
  • Table 329. Animal Model Sales Mice , by Region K Units (2019-2024)
  • Table 330. Animal Model Sales Rabbits , by Region K Units (2019-2024)
  • Table 331. Animal Model Sales Dogs , by Region K Units (2019-2024)
  • Table 332. Animal Model Sales Pigs , by Region K Units (2019-2024)
  • Table 333. Animal Model Sales Cats , by Region K Units (2019-2024)
  • Table 334. Animal Model Sales Others , by Region K Units (2019-2024)
  • Table 335. Animal Model Sales: by Application(K Units)
  • Table 336. Animal Model Sales Physiology , by Region K Units (2019-2024)
  • Table 337. Animal Model Sales Toxicology , by Region K Units (2019-2024)
  • Table 338. Animal Model Sales Cancer Research , by Region K Units (2019-2024)
  • Table 339. Animal Model Sales Neurological Research , by Region K Units (2019-2024)
  • Table 340. Animal Model Sales Biomedical Research , by Region K Units (2019-2024)
  • Table 341. Animal Model Sales Genetic Research , by Region K Units (2019-2024)
  • Table 342. Animal Model Sales Xenotransplantation , by Region K Units (2019-2024)
  • Table 343. Animal Model Sales: by End User(K Units)
  • Table 344. Animal Model Sales Academic & Research Institutions , by Region K Units (2019-2024)
  • Table 345. Animal Model Sales Pharmaceutical Companies , by Region K Units (2019-2024)
  • Table 346. Animal Model Sales Biotechnology Companies , by Region K Units (2019-2024)
  • Table 347. Animal Model Sales Contract Research Organizations (CROs) , by Region K Units (2019-2024)
  • Table 348. Animal Model Sales Others , by Region K Units (2019-2024)
  • Table 349. South America Animal Model Sales, by Country K Units (2019-2024)
  • Table 350. South America Animal Model Sales, by Type K Units (2019-2024)
  • Table 351. South America Animal Model Sales, by Application K Units (2019-2024)
  • Table 352. South America Animal Model Sales, by End User K Units (2019-2024)
  • Table 353. Brazil Animal Model Sales, by Type K Units (2019-2024)
  • Table 354. Brazil Animal Model Sales, by Application K Units (2019-2024)
  • Table 355. Brazil Animal Model Sales, by End User K Units (2019-2024)
  • Table 356. Argentina Animal Model Sales, by Type K Units (2019-2024)
  • Table 357. Argentina Animal Model Sales, by Application K Units (2019-2024)
  • Table 358. Argentina Animal Model Sales, by End User K Units (2019-2024)
  • Table 359. Rest of South America Animal Model Sales, by Type K Units (2019-2024)
  • Table 360. Rest of South America Animal Model Sales, by Application K Units (2019-2024)
  • Table 361. Rest of South America Animal Model Sales, by End User K Units (2019-2024)
  • Table 362. Asia Pacific Animal Model Sales, by Country K Units (2019-2024)
  • Table 363. Asia Pacific Animal Model Sales, by Type K Units (2019-2024)
  • Table 364. Asia Pacific Animal Model Sales, by Application K Units (2019-2024)
  • Table 365. Asia Pacific Animal Model Sales, by End User K Units (2019-2024)
  • Table 366. China Animal Model Sales, by Type K Units (2019-2024)
  • Table 367. China Animal Model Sales, by Application K Units (2019-2024)
  • Table 368. China Animal Model Sales, by End User K Units (2019-2024)
  • Table 369. Japan Animal Model Sales, by Type K Units (2019-2024)
  • Table 370. Japan Animal Model Sales, by Application K Units (2019-2024)
  • Table 371. Japan Animal Model Sales, by End User K Units (2019-2024)
  • Table 372. India Animal Model Sales, by Type K Units (2019-2024)
  • Table 373. India Animal Model Sales, by Application K Units (2019-2024)
  • Table 374. India Animal Model Sales, by End User K Units (2019-2024)
  • Table 375. South Korea Animal Model Sales, by Type K Units (2019-2024)
  • Table 376. South Korea Animal Model Sales, by Application K Units (2019-2024)
  • Table 377. South Korea Animal Model Sales, by End User K Units (2019-2024)
  • Table 378. Taiwan Animal Model Sales, by Type K Units (2019-2024)
  • Table 379. Taiwan Animal Model Sales, by Application K Units (2019-2024)
  • Table 380. Taiwan Animal Model Sales, by End User K Units (2019-2024)
  • Table 381. Australia Animal Model Sales, by Type K Units (2019-2024)
  • Table 382. Australia Animal Model Sales, by Application K Units (2019-2024)
  • Table 383. Australia Animal Model Sales, by End User K Units (2019-2024)
  • Table 384. Rest of Asia-Pacific Animal Model Sales, by Type K Units (2019-2024)
  • Table 385. Rest of Asia-Pacific Animal Model Sales, by Application K Units (2019-2024)
  • Table 386. Rest of Asia-Pacific Animal Model Sales, by End User K Units (2019-2024)
  • Table 387. Europe Animal Model Sales, by Country K Units (2019-2024)
  • Table 388. Europe Animal Model Sales, by Type K Units (2019-2024)
  • Table 389. Europe Animal Model Sales, by Application K Units (2019-2024)
  • Table 390. Europe Animal Model Sales, by End User K Units (2019-2024)
  • Table 391. Germany Animal Model Sales, by Type K Units (2019-2024)
  • Table 392. Germany Animal Model Sales, by Application K Units (2019-2024)
  • Table 393. Germany Animal Model Sales, by End User K Units (2019-2024)
  • Table 394. France Animal Model Sales, by Type K Units (2019-2024)
  • Table 395. France Animal Model Sales, by Application K Units (2019-2024)
  • Table 396. France Animal Model Sales, by End User K Units (2019-2024)
  • Table 397. Italy Animal Model Sales, by Type K Units (2019-2024)
  • Table 398. Italy Animal Model Sales, by Application K Units (2019-2024)
  • Table 399. Italy Animal Model Sales, by End User K Units (2019-2024)
  • Table 400. United Kingdom Animal Model Sales, by Type K Units (2019-2024)
  • Table 401. United Kingdom Animal Model Sales, by Application K Units (2019-2024)
  • Table 402. United Kingdom Animal Model Sales, by End User K Units (2019-2024)
  • Table 403. Netherlands Animal Model Sales, by Type K Units (2019-2024)
  • Table 404. Netherlands Animal Model Sales, by Application K Units (2019-2024)
  • Table 405. Netherlands Animal Model Sales, by End User K Units (2019-2024)
  • Table 406. Rest of Europe Animal Model Sales, by Type K Units (2019-2024)
  • Table 407. Rest of Europe Animal Model Sales, by Application K Units (2019-2024)
  • Table 408. Rest of Europe Animal Model Sales, by End User K Units (2019-2024)
  • Table 409. MEA Animal Model Sales, by Country K Units (2019-2024)
  • Table 410. MEA Animal Model Sales, by Type K Units (2019-2024)
  • Table 411. MEA Animal Model Sales, by Application K Units (2019-2024)
  • Table 412. MEA Animal Model Sales, by End User K Units (2019-2024)
  • Table 413. Middle East Animal Model Sales, by Type K Units (2019-2024)
  • Table 414. Middle East Animal Model Sales, by Application K Units (2019-2024)
  • Table 415. Middle East Animal Model Sales, by End User K Units (2019-2024)
  • Table 416. Africa Animal Model Sales, by Type K Units (2019-2024)
  • Table 417. Africa Animal Model Sales, by Application K Units (2019-2024)
  • Table 418. Africa Animal Model Sales, by End User K Units (2019-2024)
  • Table 419. North America Animal Model Sales, by Country K Units (2019-2024)
  • Table 420. North America Animal Model Sales, by Type K Units (2019-2024)
  • Table 421. North America Animal Model Sales, by Application K Units (2019-2024)
  • Table 422. North America Animal Model Sales, by End User K Units (2019-2024)
  • Table 423. United States Animal Model Sales, by Type K Units (2019-2024)
  • Table 424. United States Animal Model Sales, by Application K Units (2019-2024)
  • Table 425. United States Animal Model Sales, by End User K Units (2019-2024)
  • Table 426. Canada Animal Model Sales, by Type K Units (2019-2024)
  • Table 427. Canada Animal Model Sales, by Application K Units (2019-2024)
  • Table 428. Canada Animal Model Sales, by End User K Units (2019-2024)
  • Table 429. Mexico Animal Model Sales, by Type K Units (2019-2024)
  • Table 430. Mexico Animal Model Sales, by Application K Units (2019-2024)
  • Table 431. Mexico Animal Model Sales, by End User K Units (2019-2024)
  • Table 432. Animal Model: by Type(USD/Units)
  • Table 433. Research Programs/Design for This Report
  • Table 434. Key Data Information from Secondary Sources
  • Table 435. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Model: by Type USD Million (2013-2018)
  • Figure 5. Global Animal Model: by Application USD Million (2013-2018)
  • Figure 6. Global Animal Model: by End User USD Million (2013-2018)
  • Figure 7. South America Animal Model Share (%), by Country
  • Figure 8. Asia Pacific Animal Model Share (%), by Country
  • Figure 9. Europe Animal Model Share (%), by Country
  • Figure 10. MEA Animal Model Share (%), by Country
  • Figure 11. North America Animal Model Share (%), by Country
  • Figure 12. Global Animal Model: by Type K Units (2013-2018)
  • Figure 13. Global Animal Model: by Application K Units (2013-2018)
  • Figure 14. Global Animal Model: by End User K Units (2013-2018)
  • Figure 15. South America Animal Model Share (%), by Country
  • Figure 16. Asia Pacific Animal Model Share (%), by Country
  • Figure 17. Europe Animal Model Share (%), by Country
  • Figure 18. MEA Animal Model Share (%), by Country
  • Figure 19. North America Animal Model Share (%), by Country
  • Figure 20. Global Animal Model: by Type USD/Units (2013-2018)
  • Figure 21. Global Animal Model share by Players 2018 (%)
  • Figure 22. Global Animal Model share by Players (Top 3) 2018(%)
  • Figure 23. Global Animal Model share by Players (Top 5) 2018(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Charles River Laboratories International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Charles River Laboratories International, Inc. (United States) Revenue: by Geography 2018
  • Figure 27. Horizon Discovery Group plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Horizon Discovery Group plc (United Kingdom) Revenue: by Geography 2018
  • Figure 29. Advinus Therapeutics Limited (India) Revenue, Net Income and Gross profit
  • Figure 30. Advinus Therapeutics Limited (India) Revenue: by Geography 2018
  • Figure 31. Jackson Laboratory (United States) Revenue, Net Income and Gross profit
  • Figure 32. Jackson Laboratory (United States) Revenue: by Geography 2018
  • Figure 33. Trans Genic Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Trans Genic Inc. (Japan) Revenue: by Geography 2018
  • Figure 35. Taconic Biosciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Taconic Biosciences, Inc. (United States) Revenue: by Geography 2018
  • Figure 37. Genoway SA (France) Revenue, Net Income and Gross profit
  • Figure 38. Genoway SA (France) Revenue: by Geography 2018
  • Figure 39. Eurofins Scientific SE (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 40. Eurofins Scientific SE (Luxembourg) Revenue: by Geography 2018
  • Figure 41. Crown Bioscience, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Crown Bioscience, Inc. (United States) Revenue: by Geography 2018
  • Figure 43. Envigo CRS SA (Spain) Revenue, Net Income and Gross profit
  • Figure 44. Envigo CRS SA (Spain) Revenue: by Geography 2018
  • Figure 45. Global Animal Model: by Type USD Million (2019-2024)
  • Figure 46. Global Animal Model: by Application USD Million (2019-2024)
  • Figure 47. Global Animal Model: by End User USD Million (2019-2024)
  • Figure 48. South America Animal Model Share (%), by Country
  • Figure 49. Asia Pacific Animal Model Share (%), by Country
  • Figure 50. Europe Animal Model Share (%), by Country
  • Figure 51. MEA Animal Model Share (%), by Country
  • Figure 52. North America Animal Model Share (%), by Country
  • Figure 53. Global Animal Model: by Type K Units (2019-2024)
  • Figure 54. Global Animal Model: by Application K Units (2019-2024)
  • Figure 55. Global Animal Model: by End User K Units (2019-2024)
  • Figure 56. South America Animal Model Share (%), by Country
  • Figure 57. Asia Pacific Animal Model Share (%), by Country
  • Figure 58. Europe Animal Model Share (%), by Country
  • Figure 59. MEA Animal Model Share (%), by Country
  • Figure 60. North America Animal Model Share (%), by Country
  • Figure 61. Global Animal Model: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Charles River Laboratories International, Inc. (United States)
  • Horizon Discovery Group plc (United Kingdom)
  • Advinus Therapeutics Limited (India)
  • Jackson Laboratory (United States)
  • Trans Genic Inc. (Japan)
  • Taconic Biosciences, Inc. (United States)
  • Genoway SA (France)
  • Eurofins Scientific SE (Luxembourg)
  • Crown Bioscience, Inc. (United States)
  • Envigo CRS SA (Spain)
Additional players considered in the study are as follows:
Beijing Vital Star Biotechnology (China) , Pharmalegacy Biotechnology (China) , Pharmaron, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation